实用肝脏病杂志
實用肝髒病雜誌
실용간장병잡지
JOURNAL OF CLINICAL HEPATOLOGY
2013年
5期
424-426
,共3页
郜玉峰%汤磊%戴金津%邹桂舟%李旭
郜玉峰%湯磊%戴金津%鄒桂舟%李旭
고옥봉%탕뢰%대금진%추계주%리욱
慢性乙型肝炎%肝细胞癌%肝硬化%白细胞介素12%免疫组化
慢性乙型肝炎%肝細胞癌%肝硬化%白細胞介素12%免疫組化
만성을형간염%간세포암%간경화%백세포개소12%면역조화
Hepatitis B%Hepatocellular carcinoma%Cirrhosis%Interleukin-12%Immunohistochemical staining
目的探讨乙型肝炎病毒感染者肝组织白细胞介素12(IL-12)表达与临床表现和肝脏病理学变化的关系。方法应用免疫组化法检测9例正常肝脏组织、183例慢性乙型肝炎(CHB)、41例乙型肝炎肝硬化、37例HBV相关肝癌患者肝组织IL-12表达情况,并与临床特点和病理分级等进行相关性分析。结果 CHB患者肝组织IL-12以弱阳性表达为主,阳性和强阳性表达的比例仅为26.8%,而肝硬化和肝癌患者阳性和强阳性表达的比例分别为36.6%和48.6%,均显著高于CHB患者(P<0.05);HBeAg阴转且HBV DNA阴转的CHB患者肝内IL-12阳性表达比例为64.3%,显著高于HBeAg阳性伴肝功能异常者(30.0%)和肝功能正常者(20.4%)(P<0.05);未发现IL-12表达与肝脏炎症分级或纤维化分期具有相关性。结论 IL-12可能参与HBV感染后的疾病进展与转归。
目的探討乙型肝炎病毒感染者肝組織白細胞介素12(IL-12)錶達與臨床錶現和肝髒病理學變化的關繫。方法應用免疫組化法檢測9例正常肝髒組織、183例慢性乙型肝炎(CHB)、41例乙型肝炎肝硬化、37例HBV相關肝癌患者肝組織IL-12錶達情況,併與臨床特點和病理分級等進行相關性分析。結果 CHB患者肝組織IL-12以弱暘性錶達為主,暘性和彊暘性錶達的比例僅為26.8%,而肝硬化和肝癌患者暘性和彊暘性錶達的比例分彆為36.6%和48.6%,均顯著高于CHB患者(P<0.05);HBeAg陰轉且HBV DNA陰轉的CHB患者肝內IL-12暘性錶達比例為64.3%,顯著高于HBeAg暘性伴肝功能異常者(30.0%)和肝功能正常者(20.4%)(P<0.05);未髮現IL-12錶達與肝髒炎癥分級或纖維化分期具有相關性。結論 IL-12可能參與HBV感染後的疾病進展與轉歸。
목적탐토을형간염병독감염자간조직백세포개소12(IL-12)표체여림상표현화간장병이학변화적관계。방법응용면역조화법검측9례정상간장조직、183례만성을형간염(CHB)、41례을형간염간경화、37례HBV상관간암환자간조직IL-12표체정황,병여림상특점화병리분급등진행상관성분석。결과 CHB환자간조직IL-12이약양성표체위주,양성화강양성표체적비례부위26.8%,이간경화화간암환자양성화강양성표체적비례분별위36.6%화48.6%,균현저고우CHB환자(P<0.05);HBeAg음전차HBV DNA음전적CHB환자간내IL-12양성표체비례위64.3%,현저고우HBeAg양성반간공능이상자(30.0%)화간공능정상자(20.4%)(P<0.05);미발현IL-12표체여간장염증분급혹섬유화분기구유상관성。결론 IL-12가능삼여HBV감염후적질병진전여전귀。
Objective To investigate the relationship between interleukin-12(IL-12) expression in liver tis-sues and the clinical significance in patients with hepatitis B virus infection-associated liver diseases. Methods IL-12 expression in the liver tissues of 183 patients with CHB,41 patients with liver cirrhosis and 37 patients with HCC was detected by immunohistochemical staining; The correlation of IL-12 expression to clinical features and pathological grading and staging was analyzed. Results IL-12 expression was mild positive in liver tissues from CHB patients,but was much stronger in cirrhotic and HCC patients;The positive and strong positive rates of IL-12 expression in patients with cirrhosis and with HCC were 36.6% and 48.6%,respectively,significantly higher than that in CHB patients (26.8%,P<0.05);The positive rate of IL-12 in CHB patients with HBeAg negative and HBV DNA loss was 64.3%,significantly higher than that in CHB patients with HbeAg positive and HBV DNA positive (30.0%,P<0.05);There was no correlation between the expression of IL-12 and liver inflammation grading and fi-brosis staging. Conclusions IL-12 may be involved in the disease progression and outcome of patients with chronic hepatitis B viral infection.